Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: Protagonist, Gemphire, Kadmon Launches Fall Flat

trading

Related Content

IPO Update: With No New Offerings, Kadmon Steals The Spotlight

Jun 16 2016

IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic

Jul 22 2016

StemCells Inc. To Wind Down Operations After Phase II Failure

Jun 01 2016

Related Companies

Protagonist Therapeutics, Inc.

Gemphire Therapeutics, Inc.

AveXis, Inc.

Proteostasis Therapeutics, Inc.

Editas Medicine

Microbot Medical Inc.

inVentiv Health Inc.

Astellas Gene Therapies

Syros Pharmaceuticals, Inc.

Selecta Biosciences, Inc.

Clearside Biomedical, Inc.

Moleculin Biotech, Inc.

Reata Pharmaceuticals, Inc.

Merus N.V.

PhaseRx, Inc.

Outlook Therapeutics, Inc.

Spring Bank Pharmaceuticals Inc.

Intellia Therapeutics, Inc.

Spyre Therapeutics, Inc.

Corvus Pharmaceuticals, Inc.

HUTCHMED (China) Limited

Syndax Pharmaceuticals, Inc.

BeOne Medicines Ltd.

Additional Topics

Commercial Business Strategies BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window